Cargando…
Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features
BACKGROUND: Current standard of care for oropharyngeal cancers with positive surgical margins and/or extracapsular extension is adjuvant chemoradiotherapy. It is unknown whether HPV+ oropharyngeal cancer benefits from this treatment intensification. OBJECTIVE: To investigate the outcomes of HPV+ pat...
Autores principales: | Su, William, Liu, Jerry, Miles, Brett A., Genden, Eric M., Misiukiewicz, Krzysztof J., Posner, Marshall, Gupta, Vishal, Bakst, Richard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145232/ https://www.ncbi.nlm.nih.gov/pubmed/27930732 http://dx.doi.org/10.1371/journal.pone.0168061 |
Ejemplares similares
-
The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer
por: Dave, Eesha, et al.
Publicado: (2017) -
Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up
por: Takahashi, Mai, et al.
Publicado: (2022) -
Functional Larynx Preservation in Patients With Locally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Treated With Induction Chemotherapy vs. Concurrent Chemoradiation Alone
por: Nehlsen, Anthony D, et al.
Publicado: (2021) -
The prognostic significance of human papilloma virus in sinonasal squamous cell carcinoma
por: Schlussel Markovic, Emily, et al.
Publicado: (2020) -
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) – study protocol for a phase II non-randomized non-inferiority trial
por: Chai, Raymond L., et al.
Publicado: (2022)